Biomerica (BMRA)
(Delayed Data from NSDQ)
$0.67 USD
-0.01 (-1.51%)
Updated Apr 26, 2024 03:59 PM ET
After-Market: $0.68 +0.01 (2.22%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMBalance Sheet
Fiscal Year End for Biomerica, Inc falls in the month of May.
All items in Millions except Per Share data.
5/31/2023 | 5/31/2022 | 5/31/2021 | 5/31/2020 | 5/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 10 | 6 | 4 | 9 | 1 |
Receivables | 1 | 1 | 1 | 2 | 1 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 2 | 2 | 3 | 3 | 2 |
Other Current Assets | 0 | 0 | 0 | 2 | 0 |
Total Current Assets | 13 | 9 | 9 | 15 | 4 |
Net Property & Equipment | 0 | 0 | 0 | 0 | 0 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 0 | 0 | 0 | 0 | 0 |
Deposits & Other Assets | 0 | 0 | 0 | 0 | 0 |
Total Assets | 14 | 11 | 12 | 17 | 5 |
Liabilities & Shareholders Equity | 5/31/2023 | 5/31/2022 | 5/31/2021 | 5/31/2020 | 5/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 1 | 1 | 1 | 1 | 1 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 1 | 1 | 0 | 0 | 0 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 2 | 2 | 1 | 1 | 1 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 3 | 3 | 3 | 3 | 1 |
Shareholders Equity | 5/31/2023 | 5/31/2022 | 5/31/2021 | 5/31/2020 | 5/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 1 | 1 | 1 | 1 | 1 |
Capital Surplus | 53 | 42 | 37 | 35 | 23 |
Retained Earnings | -42 | -35 | -28 | -22 | -20 |
Other Equity | 0 | 0 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 12 | 8 | 9 | 14 | 4 |
Total Liabilities & Shareholder's Equity | 14 | 11 | 12 | 17 | 5 |
Total Common Equity | 12 | 8 | 9 | 14 | 4 |
Shares Outstanding | 16.80 | 12.80 | 12.30 | 9.80 | 9.60 |
Book Value Per Share | 0.70 | 0.65 | 0.75 | 1.45 | 0.41 |
Fiscal Year End for Biomerica, Inc falls in the month of May.
All items in Millions except Per Share data.
2/29/2024 | 11/30/2023 | 8/31/2023 | 5/31/2023 | 2/28/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 5 | 7 | 8 | 10 | 3 |
Receivables | 1 | 1 | 1 | 1 | 1 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 2 | 2 | 2 | 2 | 2 |
Other Current Assets | 0 | 0 | 0 | 0 | 0 |
Total Current Assets | 9 | 10 | 12 | 13 | 6 |
Net Property & Equipment | 0 | 0 | 0 | 0 | 0 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 0 | 0 | 0 | 0 | 0 |
Deposits & Other Assets | 0 | 0 | 0 | 0 | 0 |
Total Assets | 10 | 12 | 13 | 14 | 8 |
Liabilities & Shareholders Equity | 2/29/2024 | 11/30/2023 | 8/31/2023 | 5/31/2023 | 2/28/2023 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 1 | 1 | 1 | 1 | 0 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 1 | 1 | 1 | 1 | 1 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 2 | 2 | 2 | 2 | 1 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 0 | 0 | 0 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 3 | 2 | 2 | 3 | 2 |
Shareholders Equity | 2/29/2024 | 11/30/2023 | 8/31/2023 | 5/31/2023 | 2/28/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 1 | 1 | 1 | 1 | 1 |
Capital Surplus | 53 | 53 | 53 | 53 | 45 |
Retained Earnings | -47 | -45 | -43 | -42 | -40 |
Other Equity | 0 | 0 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 8 | 9 | 11 | 12 | 6 |
Total Liabilities & Shareholder's Equity | 10 | 12 | 13 | 14 | 8 |
Total Common Equity | 8 | 9 | 11 | 12 | 6 |
Shares Outstanding | 16.80 | 16.80 | 15.50 | 16.80 | 16.80 |
Book Value Per Share | 0.46 | 0.56 | 0.69 | 0.70 | 0.36 |